First Page | Meta Content | |
---|---|---|
Document Date: 2014-08-19 17:28:32Open Document File Size: 177,51 KBShare Result on FacebookCompanyDanone / ELANA / Genmab / Medical Center Utrecht Heidelberglaan 100 3584 CX / /ContinentEurope / /CountryGermany / Netherlands / United States / Canada / United Kingdom / /CurrencyEUR / / /FacilityNational Institute / Hubrecht Institute / University Medical Center Utrecht / Utrecht University / Utrecht University Utrecht University / HU University of Applied Sciences Utrecht / /IndustryTermtreatment of these diseases / cancer Treating / high tech approach / techno logical solutions / treatment of cancer / Cancer Care / /MedicalConditionrare / serious gastrointes tinal diseases / vascular disease / target diseases / ALS / small tumors / microvillus inclusion disease / chronic inflammation / elusive cancer Treating liver cancer / Breast cancer / orphan diseases / example aneurysms / chronic disorders / tumor / ADHD / gastro-intestinal cancer / cancer / Opportunistic infections / schizophrenia / tumors / disease / Atherosclerosis / epithelial bowel disorders / autism / currently untreatable liver cancer / stroke / respiratory infections / bipolar disorders / heart failure / diseases / widespread gastrointestinal diseases / personalized cancer / Infection / colon cancer metastases / /MedicalTreatmentradiation / /OrganizationNational Institute for Public Health and the Environment / Executive Board / Hubrecht Institute / Utrecht University / HU University of Applied Sciences Utrecht / /PersonRick Grobbee / Erik Hack / Edward Nieuwenhuis / René Kahn / Hans Clevers / / /PositionPsychiatrist / Dean and Vice Chairman / neurosurgeon / /Technologyradiation / transplantation / stem cells / regenerative medicine / /URLwww.umcutrecht.nl/research / www.umcutrecht.nl/internationaloffice / /SocialTag |